Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    PTC Therapeutics Inc.

    NASDAQ: PTCT · Real-Time Price · USD
    51.79
    0.53 (1.03%)
    At close: Jun 16, 2025, 3:59 PM
    51.62
    -0.33%
    After-hours: Jun 16, 2025, 05:38 PM EDT

    PTC Therapeutics Statistics

    Share Statistics

    PTC Therapeutics has 79.26M shares outstanding. The number of shares has increased by 2.83% in one year.

    Shares Outstanding

    n/a
    		 79.26M

    Shares Change (YoY)

    n/a
    		 2.83%

    Shares Change (QoQ)

    n/a
    		 2.26%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 77.14M

    Failed to Deliver (FTD) Shares

    n/a
    		 7

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 4.75M, so 6% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.75M

    Short % of Shares Out

    n/a
    		 6%

    Short % of Float

    n/a
    		 6.89%

    Short Ratio (days to cover)

    n/a
    		 5.3

    Valuation Ratios

    The PE ratio is -9.55 and the forward PE ratio is -21.69. PTC Therapeutics's PEG ratio is 0.22.

    PE Ratio

    n/a
    		 -9.55

    Forward PE

    n/a
    		 -21.69

    PS Ratio

    n/a
    		 4.3

    Forward PS

    n/a
    		 2.9

    PB Ratio

    n/a
    		 -3.16

    P/FCF Ratio

    n/a
    		 -30.38

    PEG Ratio

    n/a
    		 0.22
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for PTC Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.35, with a Debt / Equity ratio of -0.35.

    Current Ratio

    n/a
    		 2.35

    Quick Ratio

    n/a
    		 2.31

    Debt / Equity

    n/a
    		 -0.35

    Debt / EBITDA

    n/a
    		 -3.23

    Debt / FCF

    n/a
    		 -3.41

    Interest Coverage

    n/a
    		 -1.81

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $859,190.63

    Profits Per Employee

    n/a
    		 $-386,895.63

    Employee Count

    n/a
    		 939

    Asset Turnover

    n/a
    		 0.47

    Inventory Turnover

    n/a
    		 2.47

    Taxes

    Income Tax

    n/a
    		 176K

    Effective Tax Rate

    n/a
    		 -0.05%

    Stock Price Statistics

    The stock price has increased by 46.3% in the last 52 weeks. The beta is 0.51, so PTC Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.51

    52-Week Price Change

    n/a
    		 46.3%

    50-Day Moving Average

    n/a
    		 47.07

    200-Day Moving Average

    n/a
    		 45.13

    Relative Strength Index (RSI)

    n/a
    		 61.71

    Average Volume (20 Days)

    n/a
    		 1,221,146

    Income Statement

    In the last 12 months, PTC Therapeutics had revenue of 806.78M and earned -363.3M in profits. Earnings per share was -4.73.

    Revenue

    n/a
    		 806.78M

    Gross Profit

    n/a
    		 749.38M

    Operating Income

    n/a
    		 -302.57M

    Net Income

    n/a
    		 -363.3M

    EBITDA

    n/a
    		 -120.46M

    EBIT

    n/a
    		 -196.13M

    Earnings Per Share (EPS)

    n/a
    		 -4.73
    Full Income Statement

    Balance Sheet

    The company has 779.71M in cash and 389.3M in debt, giving a net cash position of 390.41M.

    Cash & Cash Equivalents

    n/a
    		 779.71M

    Total Debt

    n/a
    		 389.3M

    Net Cash

    n/a
    		 390.41M

    Retained Earnings

    n/a
    		 -3.65B

    Total Assets

    n/a
    		 2.66B

    Working Capital

    n/a
    		 1.72B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -107.69M and capital expenditures -6.5M, giving a free cash flow of -114.19M.

    Operating Cash Flow

    n/a
    		 -107.69M

    Capital Expenditures

    n/a
    		 -6.5M

    Free Cash Flow

    n/a
    		 -114.19M

    FCF Per Share

    n/a
    		 -1.49
    Full Cash Flow Statement

    Margins

    Gross margin is 92.89%, with operating and profit margins of -37.5% and -45.03%.

    Gross Margin

    n/a
    		 92.89%

    Operating Margin

    n/a
    		 -37.5%

    Pretax Margin

    n/a
    		 -45.01%

    Profit Margin

    n/a
    		 -45.03%

    EBITDA Margin

    n/a
    		 -14.93%

    EBIT Margin

    n/a
    		 -37.5%

    FCF Margin

    n/a
    		 -14.15%

    Dividends & Yields

    PTCT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PTCT is $66, which is 27.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $66

    Price Target Difference

    n/a
    		 27.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 12
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.8

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist